Tom McGrath has been appointed director of Quality for Aseptic Services at AMRI’s Burlington, MA site. He reports to Junan Guo, Ph.D., senior director of Pharmaceutical and Quality Services.
 
Mr. McGrath has more than 15 years of experience in the pharmaceutical industry, having held leadership positions overseeing quality control with multiple biopharma companies. Most recently he served as Quality Control director at AMAG Pharmaceuticals.
 
AMRI’s Burlington facility offers aseptic formulation and filling services for pre-clinical through small-volume, commercial-scale production of liquid-filled parenterals, biologics and medical devices in vials, syringes and other custom containers.
 
“Tom brings extensive knowledge and experience in quality systems enabling product development and commercialization,” said Steven R. Hagen, Ph.D., vice president, Pharmaceutical Development and Manufacturing, AMRI. “With the established quality systems at AMRI Burlington, Tom’s leadership will further ensure our objective of providing industry leading quality standards and product performance for our customers.”
 
In addition, Chris Phillips has been appointed senior director of operations at the Burlington site. Working with Mr. McGrath, Mr. Phillips will continue to focus on ensuring that customer projects at the site are managed to completion in accordance with FDA standards for the aseptic fill and finish.